COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 417: Articles 4161-4170  | Next

User adherence and perceptions of a Volunteer-Led Telemonitoring and Teleorientation Service for COVID-19 community management in Peru: The COVIDA project
Escobar-Agreda, S., Silva-Valencia, J., Soto-Becerra, P., Reategui-Rivera, C. M., De la Cruz-Torralva, K., Chahuara-Rojas, M., Hernandez-Iriarte, B., Espinoza-Herrera, D. H., Delgado, C. A., Matassini Eyzaguirre, S. M., Vargas-Herrera, J. R., Rojas-Mezarina, L.
10.1101/2023.06.08.23291037 — Posted: 2023-06-12
Sustainability Indexes as Possible Predictors of Excess Mortality across OECD Countries during the Covid-19 Pandemic
LIU, L.
10.1101/2023.06.09.23291035 — Posted: 2023-06-12
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland
Drysdale, M., Tibble, H., Patel, V., Gibbons, D. C., Lloyd, E., Kerr, W., Macdonald, C., Birch, H., Sheikh, A.
10.1101/2023.06.09.23291195 — Posted: 2023-06-12
Risk of Coronavirus Disease 2019 (COVID-19) among Those Up-to-Date and Not Up-to-Date on COVID-19 Vaccination
Shrestha, N. K., Burke, P. C., Nowacki, A. S., Gordon, S. M.
10.1101/2023.06.09.23290893 — Posted: 2023-06-12
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment.
Faliti, C. E., Anam, F., Cheedarla, N., Woodruff, M., Usman, S., Runnstrom, M., Van, T., Kyu, S., Ahmed, H., Morrison-Porter, A., Quehl, H., Haddad, N. S., Chen, W., Cheedarla, S., Neish, A., Roback, J. D., Antia, R., Khosroshahi, A., Lee, F. E.-H., Sanz, I.
10.1101/2023.06.08.23291159 — Posted: 2023-06-12
Assessment of the relationship between Google Trend search data on clinical symptoms and cases reported during the first wave of the COVID-19 outbreak in India.
Mutheneni, S. R., Vavilala, H., Mopuri, R.
10.1101/2023.06.08.23291183 — Posted: 2023-06-12
Global seasonal activities of respiratory syncytial virus before the COVID-19 pandemic: a systematic review
Shan, S., Zhang, W., Gao, H., Huang, P.-Y., Du, Z., Bai, Y., Lau, Y.-C., Chen, D., Lau, E. H., Nealon, J., Wu, P.
10.1101/2023.06.12.23291266 — Posted: 2023-06-12
SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia
Janha, R. E., Bah, A., Jah, H., Touray, F., Idris, Y., Keita, S., Gaye, Y., Jallow, S., Faye-Joof, T., Njie, B., Craik, R., Mohammed, N. I., von Dadelszen, P., D'Alessandro, U., Roca, A.
10.1101/2023.06.09.23291201 — Posted: 2023-06-12
SARS-CoV-2 Spread Under the Controlled-Distancing Model of Rio Grande do Sul, Brazil
Rohweder, R., Schuler-Faccini, L., Ferraz, G.
10.1101/2023.06.09.23291044 — Posted: 2023-06-12
Low Dose Naltrexone use for the management of post acute sequelae of COVID 19
Bonilla, H., Tian, L., Marconi, V., Shafer, R. W., Mccomsey, G., Miglis, M. G., Yang, P. C., Geng, L. N.
10.1101/2023.06.08.23291102 — Posted: 2023-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).